Abstract
Out of a total of 47,005 cases of primary breast cancer with curative surgery recorded in Japan in the 20 year period from 1963 to 1982, 764, or 1.6 per cent had a second primary cancer occurring during the same period. The distribution of the second site was gastric cancer in 200 (26.2 per cent), breast cancer in 200 (26.2 per cent), colorectal cancer in 59 (7.7 per cent), cancer of the cervix uteri in 54 (7.1 per cent) and thyroid cancer in 37 (4.8 per cent). The gastric cancer was the Borrmann type 4, and the poorly differentiated scirrhous type. Incidence of the second cancer was enhanced, in the first period before 1971 and by contrast, in the second period after 1971 it was diminished. In the chemotherapy (+) group, the occurrence of the second cancer seemed to be strongly influenced by mitomycin C. In the radiotherapy prescribed group, leukemia was as frequent as esophageal cancer, and in those given endocrine therapy, breast cancer strongly inhibited the current one.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Statistics and Information, Department of Minister's Secretariat, Ministry of Health and Welfare, Vital Statistics 1980, Japan.
Warren S, Gates O. Multiple primary malignant tumor: A survey of the literature and statistical study. Am J Cancer 1932; 16: 1358–1414.
Japan Mammary Cancer Society. General rule for clinical and histological record of mammary cancer. Jpn J Surg 1975; 5: 118–131.
Japanese Research Society for Gastric Cancer. General rules for the gastric cancer study in surgery and pathology. Jpn J Surg 1981; 11: 127–145.
Osaka Cancer Registry, Cancer Incidence in Osaka. No. 1-35, Osaka, 1963–1984.
Miyagi Prefectural Cancer Registry Miyagi Cancer Society, Sendai 1978. Cancer registration in Miyagi Prefecture, Cancer incidence in Miyagi Prefecture. Japan, 1959–1973.
Japan Mammary Cancer Society, Joint Committee for Mammary Cancer in Japan. A report of clinical statistical studies on registered mammary cancer patients in Japan. No. 1-3, 1975–1977.
Japanese Research Society for Gastric Cancer National Cancer Center, Tokyo. A report of treatment and results of stomach carcinoma in Japan. No. 1-14, 1967–1973.
Schoenberg B, Myer M. Statistical methods for studying multiple primary malignant neoplasms. Cancer 1977; 40: 1892–1898.
Akasaki, T, Wakasa H, Ishinodate T. Multiple primary cancers. Nippon Rinsho 1961; 19: 1543–1551. (in Japanese)
Moertel CG, Docherty MB, Baggestors AH. Multiple primary malignant neoplasms. Cancer 1961: 14: 221–248.
Slack NH, Bross IJ, Nemoto T. Experiences with bilateral primary carcinoma of the breast. Surg Gynecol Obstet 1973; 136: 433–440.
Murata M, Kuno K, Fukami A, Sakamoto G. Epidemiology of familial predisposition for breast cancer in Japan. J Natl Cancer Inst 1982; 69: 1229–1234.
Hislop TG, elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast: incidence and risk factors. Br J Cancer 1984; 49: 79–85.
Ron E, Curtis R, Hoffman DA, Flannery JT. Multiple primary breast and thyroid cancer. Br J Cancer 1984; 49: 87–92.
Lynch HT, Harris RE, Guirgis HA, Maloney K, Carmody LL, Lynch JF. Familial association of breast/ovarian carcinoma. Cancer 1978; 41: 1543–1549.
Prior P, Waterhouse JAH. Multiple primary cancers of breast and cervix uteri: an epidemiological approach to analysis. Br J Cancer 1981; 43: 623–531.
Holdener EE., Osterwalder J, Senn HJ, Enderlin F, Gloor F. Zweitmalignome bei operiertem Mammakarzinom. Schweiz med Wschr 1982; 112: 1800–1804.
Schenker JG, Levinsky R, Ohel G. Multiple primary malignant neoplasms in breast cancer patients in Israel. Cancer 1984; 54: 145–150.
Furukawa H, Iwanaga T, Koyama H, Taniguchi H. Effect of sex hormones carcinogenesis in the stomachs of rats. Cancer Res 1982; 42: 5181–5182.
Hoover R, Fraumeni JF. Drug-induced cancer. Cancer 1981; 47: 1075–1081.
Koyama H, Wada T, Takahashi Y, Nishizawa Y, Iwanaga T, Aoki Y, Terasawa T, Kosaki G, Kajita A, Waka A. Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancer. Cancer 1980; 46: 2373–2379.
Penn I. Second neoplasms following radiotherapy or chemotherapy for cancer. Am J Clin Oncol 1982; 5: 83–96.
Kardinal CG, Donegan WL. Second cancers after prolonged adjuvant thiotepa for operable carcinoma of the breast. Cancer 1980; 45: 2042–2046.
Boice JD. Cancer following medical irradiation. Cancer 1981; 47: 1081–1090.
Hankey BF, Curtis RE, Naughton MD, Boice JD, Flannery JT. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 1983; 70: 797–804.
McGregor DH, Land CE, Tokuoka S, Liu PI, Wakabayashi T, Beebe GW. Breast cancer incidence among atomic bomb survivors. Hiroshima and Nagasaki, 1950–1969. J Natl Cancer Inst 1977; 59: 799–811.
Hirayama T, Wynder EL. A study of the epidemiology of cancer of the breast. Cancer 1962; 15: 28–38.
Brinton LA, Hoover RN, Szklo M, Fraumeni JF. Menopausal estrogen use and risk of breast cancer. Cancer 1981; 47: 2517–2522.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwasa, Z., Jinnai, D., Koyama, H. et al. Second primary cancer following adjuvant chemotherapy, radiotherapy and endocrine therapy for breast cancer: A nationwide survey on 47,005 Japanese patients who underwent mastectomy from 1963–1982. The Japanese Journal of Surgery 16, 262–271 (1986). https://doi.org/10.1007/BF02470935
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470935